DUBLIN, Oct. 28, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/9qzjvb/2016_emerging) has announced the addition of the "2016 Emerging Strategies for the Japanese Hospital Hemostasis Diagnostics Market" report to their offering.
This new report contains 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital hemostasis diagnostic testing market, including:
Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
Volume and sales forecasts for 40 coagulation procedures performed in Japanese hospitals, including typical coagulation daily work loads.
Review of current instrumentation technologies, and a feature comparison of leading analyzers.
Reagent and instrument sales forecasts.Sales and market shares of leading reagent and instrument suppliers.
Review of coagulation technologies and their potential market applications.Major opportunities for coagulation instruments and consumables.
Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Business opportunities and strategic recommendations for instrument and reagent suppliers.
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
For more information visit http://www.researchandmarkets.com/research/9qzjvb/2016_emerging
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
